Bespak has announced the launch of the Syrina™ AR 2.25 auto-injector. This innovative auto-injector is the latest addition to the VapourSoft™ -powered Syrina range and is suitable for delivering ...
Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced positive results of a clinical study demonstrating subcutaneous administration of 10 mL of a representative biologic product ...
The global auto-injectors market is rapidly evolving, emerging as one of the most dynamic segments of medical devices and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results